<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">350763</id>
  <title nil="true"/>
  <common-name>4-[(4-chlorophenyl)methyl]-2-[1-(3-cyclohexyl-3-oxopropyl)azepan-4-yl]phthalazin-1-one</common-name>
  <description>4-[(4-chlorophenyl)methyl]-2-[1-(3-cyclohexyl-3-oxopropyl)azepan-4-yl]phthalazin-1-one is a chemical compound with the formula C30H36ClN3O2. With an average molecular weight of 506.10 g/mol, 4-[(4-chlorophenyl)methyl]-2-[1-(3-cyclohexyl-3-oxopropyl)azepan-4-yl]phthalazin-1-one is a heavy molecule.</description>
  <cas nil="true"/>
  <pubchem-id>3066440</pubchem-id>
  <chemical-formula>C30H36ClN3O2</chemical-formula>
  <weight>506.1</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-31T16:01:51Z</created-at>
  <updated-at type="dateTime">2026-08-31T16:01:51Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>C1CCC(CC1)C(=O)CCN2CCCC(CC2)N3C(=O)C4=CC=CC=C4C(=N3)CC5=CC=C(C=C5)Cl</moldb-smiles>
  <moldb-formula>C30H36ClN3O2</moldb-formula>
  <moldb-inchi>InChI=1S/C30H36ClN3O2/c31-24-14-12-22(13-15-24)21-28-26-10-4-5-11-27(26)30(36)34(32-28)25-9-6-18-33(19-16-25)20-17-29(35)23-7-2-1-3-8-23/h4-5,10-15,23,25H,1-3,6-9,16-21H2</moldb-inchi>
  <moldb-inchikey>WWRSLFMZGIGDEM-UHFFFAOYSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">505.2496051</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>6.1</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM346656</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>4-[(4-chlorophenyl)methyl]-2-[1-(3-cyclohexyl-3-oxopropyl)azepan-4-yl]phthalazin-1-one</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Organoheterocyclic compounds</superklass>
  <klass>Diazanaphthalenes</klass>
  <subklass>Benzodiazines</subklass>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0301067</sync-id>
  <structure-inchikey>WWRSLFMZGIGDEM-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>2000000000000000000080000000000000000000000000000000008000000000000000000000022000000000000000208000000000000002000000000002018000000000000040000000000010000000002000000000000000000000000004000000000001008000000100000040002000000002010000000002000000000010080000000102000080800008400000400000000000010000000000000004000000000020000400000004010008000000000202000000000000a000000000000000000008040000000080000000000000000010000000000000000220008000010000000000000000000040000040020400020000081000000040000000000000</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAkAAAAKAAAAIABBgBgAAAAAgIGAGAAAAAC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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:48:44Z</structure-indexed-at>
</compound>
